Egbert Rebecca J, Basu Puja, Refsal Kent R, Petroff Margaret G, Petroff Brian K
Michigan State University Veterinary Diagnostic Laboratory, Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI.
Pathology Services Unit, Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI.
Am J Vet Res. 2024 May 4;85(6). doi: 10.2460/ajvr.23.08.0190. Print 2024 Jun 1.
The objective of this study was to follow long-term changes in the concentration of thyroid hormones in dogs with subclinical thyroiditis.
Samples were obtained from 125 dogs with subclinical thyroiditis. The study population included 70 female and 55 male dogs. The mean testing interval was 3.9 years from initial testing (SD, 2.3 years; range, 1 to 9 years).
Dogs with subclinical thyroiditis were identified retrospectively using results from the Orthopedic Foundation for Animals Canine Thyroid Profile performed by the Endocrinology Section of the Michigan State University Veterinary Diagnostic Lab. Owners were invited to submit follow-up serum samples with their veterinarian along with a medical history form, including subsequent treatments.
At the time of retesting, 30% of the dogs had progressed to hypothyroidism and/or were treated with thyroxine. Fifty percent maintained positive or equivocal thyroglobulin autoantibody (TgAA) results while remaining euthyroid. Fourteen percent of the dogs became TgAA negative and remained euthyroid. In 6% of the cases tested, proper medical histories were not available, and a final classification could not be determined.
These results indicate that most dogs with elevated thyroglobulin autoantibodies either exhibit persistent autoimmune thyroiditis with continued risk of hypothyroidism or progress to hypothyroidism when monitored for more than 1 year. Thyroid function in dogs with subclinical thyroiditis should be monitored every 12 months or if there is change in the clinical presentation.
本研究的目的是追踪亚临床甲状腺炎犬甲状腺激素浓度的长期变化。
从125只患有亚临床甲状腺炎的犬获取样本。研究群体包括70只雌性犬和55只雄性犬。从初次检测开始的平均检测间隔为3.9年(标准差为2.3年;范围为1至9年)。
通过密歇根州立大学兽医诊断实验室内分泌科进行的动物骨科基金会犬甲状腺检测结果,回顾性识别患有亚临床甲状腺炎的犬。邀请犬主与他们的兽医一起提交随访血清样本以及一份病史表格,包括后续治疗情况。
在重新检测时,30%的犬已发展为甲状腺功能减退和/或接受了甲状腺素治疗。50%的犬甲状腺球蛋白自身抗体(TgAA)检测结果保持阳性或可疑,同时甲状腺功能正常。14%的犬TgAA检测结果变为阴性且甲状腺功能保持正常。在6%的检测病例中,没有获得合适的病史,因此无法确定最终分类。
这些结果表明,大多数甲状腺球蛋白自身抗体升高的犬,要么表现出持续性自身免疫性甲状腺炎且仍有甲状腺功能减退的风险,要么在监测超过1年后发展为甲状腺功能减退。对于患有亚临床甲状腺炎的犬,应每12个月监测一次甲状腺功能,或者在临床表现出现变化时进行监测。